Selected research
Industry Research
OTC Analgesic Gel Drug Industry Research Report 2026
Market perspective
The global OTC Analgesic Gel Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the OTC Analgesic Gel Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the OTC Analgesic Gel Drug market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the OTC Analgesic Gel Drug market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of OTC Analgesic Gel Drug include China Biopharmaceutical Co., Ltd., Jiangsu Innovent Biologics Co., Ltd., Job Care Pharmaceutical Group Co., Ltd., Hunan Jiudian Pharmaceutical Co., Ltd., Teikoku Pharma, RB Health, PERNATON, MIKASA SEIYAKU CO.,LTD and Lead Chemical CO., Ltd, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global OTC Analgesic Gel Drug market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to OTC Analgesic Gel Drug.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
OTC Analgesic Gel Drug Market by Company
China Biopharmaceutical Co., Ltd.
Jiangsu Innovent Biologics Co., Ltd.
Job Care Pharmaceutical Group Co., Ltd.
Hunan Jiudian Pharmaceutical Co., Ltd.
Teikoku Pharma
RB Health
PERNATON
MIKASA SEIYAKU CO.,LTD
Lead Chemical CO., Ltd
Kowa Company
Haleon
OTC Analgesic Gel Drug Segment by Type
Patches
Ointments
OTC Analgesic Gel Drug Segment by Application
Online Sales
Offline Sales
OTC Analgesic Gel Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Analgesic Gel Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OTC Analgesic Gel Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Analgesic Gel Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of OTC Analgesic Gel Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Patches
- Ointments
Applications
- Online Sales
- Offline Sales
Companies covered
- China Biopharmaceutical Co., Ltd.
- Jiangsu Innovent Biologics Co., Ltd.
- Job Care Pharmaceutical Group Co., Ltd.
- Hunan Jiudian Pharmaceutical Co., Ltd.
- Teikoku Pharma
- RB Health
- PERNATON
- MIKASA SEIYAKU CO.,LTD
- Lead Chemical CO., Ltd
- Kowa Company
- Haleon
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 OTC Analgesic Gel Drug by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Patches
- 2.2.3 Ointments
- 2.3 OTC Analgesic Gel Drug by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Online Sales
- 2.3.3 Offline Sales
- 2.4 Assumptions and Limitations
3 OTC Analgesic Gel Drug Breakdown Data by Type
- 3.1 Global OTC Analgesic Gel Drug Historic Market Size by Type (2021-2026)
- 3.2 Global OTC Analgesic Gel Drug Forecasted Market Size by Type (2027-2032)
4 OTC Analgesic Gel Drug Breakdown Data by Application
- 4.1 Global OTC Analgesic Gel Drug Historic Market Size by Application (2021-2026)
- 4.2 Global OTC Analgesic Gel Drug Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global OTC Analgesic Gel Drug Market Perspective (2021-2032)
- 5.2 Global OTC Analgesic Gel Drug Growth Trends by Region
- 5.2.1 Global OTC Analgesic Gel Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 OTC Analgesic Gel Drug Historic Market Size by Region (2021-2026)
- 5.2.3 OTC Analgesic Gel Drug Forecasted Market Size by Region (2027-2032)
- 5.3 OTC Analgesic Gel Drug Market Dynamics
- 5.3.1 OTC Analgesic Gel Drug Industry Trends
- 5.3.2 OTC Analgesic Gel Drug Market Drivers
- 5.3.3 OTC Analgesic Gel Drug Market Challenges
- 5.3.4 OTC Analgesic Gel Drug Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top OTC Analgesic Gel Drug Players by Revenue
- 6.1.1 Global Top OTC Analgesic Gel Drug Players by Revenue (2021-2026)
- 6.1.2 Global OTC Analgesic Gel Drug Revenue Market Share by Players (2021-2026)
- 6.2 Global OTC Analgesic Gel Drug Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of OTC Analgesic Gel Drug Head Office and Area Served
- 6.4 Global OTC Analgesic Gel Drug Players, Product Type & Application
- 6.5 Global OTC Analgesic Gel Drug Manufacturers Established Date
- 6.6 Global OTC Analgesic Gel Drug Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America OTC Analgesic Gel Drug Market Size (2021-2032)
- 7.2 North America OTC Analgesic Gel Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America OTC Analgesic Gel Drug Market Size by Country (2021-2026)
- 7.4 North America OTC Analgesic Gel Drug Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe OTC Analgesic Gel Drug Market Size (2021-2032)
- 8.2 Europe OTC Analgesic Gel Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe OTC Analgesic Gel Drug Market Size by Country (2021-2026)
- 8.4 Europe OTC Analgesic Gel Drug Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific OTC Analgesic Gel Drug Market Size (2021-2032)
- 9.2 Asia-Pacific OTC Analgesic Gel Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific OTC Analgesic Gel Drug Market Size by Country (2021-2026)
- 9.4 Asia-Pacific OTC Analgesic Gel Drug Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America OTC Analgesic Gel Drug Market Size (2021-2032)
- 10.2 South America OTC Analgesic Gel Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America OTC Analgesic Gel Drug Market Size by Country (2021-2026)
- 10.4 South America OTC Analgesic Gel Drug Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa OTC Analgesic Gel Drug Market Size (2021-2032)
- 11.2 Middle East & Africa OTC Analgesic Gel Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa OTC Analgesic Gel Drug Market Size by Country (2021-2026)
- 11.4 Middle East & Africa OTC Analgesic Gel Drug Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 China Biopharmaceutical Co., Ltd.
- 12.1.1 China Biopharmaceutical Co., Ltd. Company Information
- 12.1.2 China Biopharmaceutical Co., Ltd. Business Overview
- 12.1.3 China Biopharmaceutical Co., Ltd. Revenue in OTC Analgesic Gel Drug Business (2021-2026)
- 12.1.4 China Biopharmaceutical Co., Ltd. OTC Analgesic Gel Drug Product Portfolio
- 12.1.5 China Biopharmaceutical Co., Ltd. Recent Developments
- 12.2 Jiangsu Innovent Biologics Co., Ltd.
- 12.2.1 Jiangsu Innovent Biologics Co., Ltd. Company Information
- 12.2.2 Jiangsu Innovent Biologics Co., Ltd. Business Overview
- 12.2.3 Jiangsu Innovent Biologics Co., Ltd. Revenue in OTC Analgesic Gel Drug Business (2021-2026)
- 12.2.4 Jiangsu Innovent Biologics Co., Ltd. OTC Analgesic Gel Drug Product Portfolio
- 12.2.5 Jiangsu Innovent Biologics Co., Ltd. Recent Developments
- 12.3 Job Care Pharmaceutical Group Co., Ltd.
- 12.3.1 Job Care Pharmaceutical Group Co., Ltd. Company Information
- 12.3.2 Job Care Pharmaceutical Group Co., Ltd. Business Overview
- 12.3.3 Job Care Pharmaceutical Group Co., Ltd. Revenue in OTC Analgesic Gel Drug Business (2021-2026)
- 12.3.4 Job Care Pharmaceutical Group Co., Ltd. OTC Analgesic Gel Drug Product Portfolio
- 12.3.5 Job Care Pharmaceutical Group Co., Ltd. Recent Developments
- 12.4 Hunan Jiudian Pharmaceutical Co., Ltd.
- 12.4.1 Hunan Jiudian Pharmaceutical Co., Ltd. Company Information
- 12.4.2 Hunan Jiudian Pharmaceutical Co., Ltd. Business Overview
- 12.4.3 Hunan Jiudian Pharmaceutical Co., Ltd. Revenue in OTC Analgesic Gel Drug Business (2021-2026)
- 12.4.4 Hunan Jiudian Pharmaceutical Co., Ltd. OTC Analgesic Gel Drug Product Portfolio
- 12.4.5 Hunan Jiudian Pharmaceutical Co., Ltd. Recent Developments
- 12.5 Teikoku Pharma
- 12.5.1 Teikoku Pharma Company Information
- 12.5.2 Teikoku Pharma Business Overview
- 12.5.3 Teikoku Pharma Revenue in OTC Analgesic Gel Drug Business (2021-2026)
- 12.5.4 Teikoku Pharma OTC Analgesic Gel Drug Product Portfolio
- 12.5.5 Teikoku Pharma Recent Developments
- 12.6 RB Health
- 12.6.1 RB Health Company Information
- 12.6.2 RB Health Business Overview
- 12.6.3 RB Health Revenue in OTC Analgesic Gel Drug Business (2021-2026)
- 12.6.4 RB Health OTC Analgesic Gel Drug Product Portfolio
- 12.6.5 RB Health Recent Developments
- 12.7 PERNATON
- 12.7.1 PERNATON Company Information
- 12.7.2 PERNATON Business Overview
- 12.7.3 PERNATON Revenue in OTC Analgesic Gel Drug Business (2021-2026)
- 12.7.4 PERNATON OTC Analgesic Gel Drug Product Portfolio
- 12.7.5 PERNATON Recent Developments
- 12.8 MIKASA SEIYAKU CO.,LTD
- 12.8.1 MIKASA SEIYAKU CO.,LTD Company Information
- 12.8.2 MIKASA SEIYAKU CO.,LTD Business Overview
- 12.8.3 MIKASA SEIYAKU CO.,LTD Revenue in OTC Analgesic Gel Drug Business (2021-2026)
- 12.8.4 MIKASA SEIYAKU CO.,LTD OTC Analgesic Gel Drug Product Portfolio
- 12.8.5 MIKASA SEIYAKU CO.,LTD Recent Developments
- 12.9 Lead Chemical CO., Ltd
- 12.9.1 Lead Chemical CO., Ltd Company Information
- 12.9.2 Lead Chemical CO., Ltd Business Overview
- 12.9.3 Lead Chemical CO., Ltd Revenue in OTC Analgesic Gel Drug Business (2021-2026)
- 12.9.4 Lead Chemical CO., Ltd OTC Analgesic Gel Drug Product Portfolio
- 12.9.5 Lead Chemical CO., Ltd Recent Developments
- 12.10 Kowa Company
- 12.10.1 Kowa Company Company Information
- 12.10.2 Kowa Company Business Overview
- 12.10.3 Kowa Company Revenue in OTC Analgesic Gel Drug Business (2021-2026)
- 12.10.4 Kowa Company OTC Analgesic Gel Drug Product Portfolio
- 12.10.5 Kowa Company Recent Developments
- 12.11 Haleon
- 12.11.1 Haleon Company Information
- 12.11.2 Haleon Business Overview
- 12.11.3 Haleon Revenue in OTC Analgesic Gel Drug Business (2021-2026)
- 12.11.4 Haleon OTC Analgesic Gel Drug Product Portfolio
- 12.11.5 Haleon Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst